« Back
Home /
Letermovir

Letermovir

Manufacturer	Molnova
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	1mg
Item no.	MOLN-M20144-1mg
Targets	HCV
CASRN	917389-32-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Brief description	Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
Molecular Weight	572, 55
Note	Research use only, not for human use.
Stability	≥ 2 years
Storage	(-20℃)
Receptor	HCV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 6/6/2024